In contrast, another study has shown that potent VEGF inhibitors, including sunitinib and ziv-aflibercept, cause tumor necrosis and downregulate CD31 and Ki-67 expression in the renal cell carcinoma PDX model, which was consistent with our results [38]. Here, VEGFA is linked to neoplasm.